menu search

Republic bancorp and norcross braca group announce $35 million investment

Investment Will Improve Capital Ratios and Result in Reconstitution of Republic Board, with Appointment of Philip A. Norcross as Chair as well as Greg...

October 27, 2023, 9:15 pm

Republic bank and norcross braca group announce signing of letter of intent

Norcross braca Group Will Invest at Least $35 Million as Part of a $75 Million Capital Raise and Will G...

September 27, 2023, 10:50 pm

Clovis enters bankruptcy with deal to sell cancer-drug candidate to novartis

Clovis Oncology, maker of ovarian cancer drug Rubraca, has filed for chapter 11 and proposed selling a ...

December 12, 2022, 2:05 pm

Td bank ceo greg braca: record cash balances at most banks in the u.s.

Greg braca, CEO of TD Bank, joins "Squawk on the Street" to discuss the consumer's view of the economy ...

November 19, 2022, 9:55 am

Clovis (clvs) up 24% on upbeat data from ovarian cancer study

Clovis Oncology's (CLVS) stock price rises after it reports favorable data from a late-stage study on Rubraca<...

April 4, 2022, 4:33 pm

Clovis oncology: forging a fresh perspective

Clovis Oncology recently reported impressive data from their ATHENA-MONO Phase III study. The ATHENA-MONO data should support the use of Ru...

March 31, 2022, 7:23 pm

Clovis oncology's rubraca significantly improves pfs in ovarian cancer regardless of biomarker status

Clovis Oncology Inc (NASDAQ: CLVS) announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Ru...

March 31, 2022, 9:34 am

Clovis oncology to seek fda approval for ovarian cancer drug as a maintenance therapy

Shares of Clovis Oncology Inc. CLVS, -3.51% soared 40.0% in premarket trading on Thursday after the company said its drug, Ru...

March 31, 2022, 8:01 am

Myriad genetics (mygn) to offer companion diagnostic for lynparza

Myriad Genetics' (MYGN) bracanalysis CDx gained FDA nod for identifying breast cancer patients eligible...

March 14, 2022, 12:02 pm

Clovis (clvs) q4 loss narrower than expected, revenues lag

Clovis (CLVS) reports narrower-than-expected loss for fourth-quarter 2021. Sales of the sole marketed drug Rub...

February 24, 2022, 4:11 pm

Clovis (clvs) q4 loss narrower than expected, revenues lag

Clovis (CLVS) reports narrower-than-expected loss for fourth-quarter 2021. Sales of the sole marketed drug Rub...

February 24, 2022, 4:11 pm

Clovis (clvs) q4 loss narrower than expected, revenues lag

Clovis (CLVS) reports narrower-than-expected loss for fourth-quarter 2021. Sales of the sole marketed drug Rub...

February 24, 2022, 4:11 pm

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sal...

December 30, 2021, 1:17 pm

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sal...

December 30, 2021, 1:17 pm

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sal...

December 30, 2021, 1:17 pm


Search within

Pages Search Results: